» Authors » Yifan Hou

Yifan Hou

Explore the profile of Yifan Hou including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 31
Citations 158
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Chang B, Zhang M, Hou Y, Li W, Li S, Zhang J, et al.
Front Oncol . 2025 Mar; 15:1464446. PMID: 40083870
Background And Purpose: Prostatic ductal adenocarcinoma (PDA) constitutes a rare and notably aggressive histological subtype within the spectrum of prostate malignancies, distinguished by a heightened propensity for recurrence and metastasis...
2.
Yang X, Weng K, Xing P, Chen J, Hao H, Liu T, et al.
FASEB J . 2025 Jan; 39(2):e70329. PMID: 39853769
Chemoresistance is an ongoing challenge for colorectal cancer (CRC) that significantly compromises the anti-tumor efficacy of current drugs. Identifying effective targets or drugs for overcoming chemoresistance is urgently needed. Our...
3.
Wang Z, Zhang Z, Yue Y, Hou Y, Cao Y, Guo C, et al.
Mol Cancer Res . 2025 Jan; 23(3):175-189. PMID: 39786453
Cancer remains one of the most formidable challenges in the medical field in this century, largely because of its poorly understood pathogenesis. Fortunately, recent advancements in the understanding of cancer...
4.
Lian Z, Hou Y, Liu L, Gu X, Kang K, Wang L, et al.
J Hazard Mater . 2024 Oct; 480:136201. PMID: 39427355
Terrestrial agricultural plastic film (APF) residue migration triggered by soil erosion constitutes a primary disruption in the plastic waste cycle. However, the migration mechanisms of APF residue and phthalate acid...
5.
Wang Z, Han H, Zhang C, Wu C, Di J, Xing P, et al.
J Exp Clin Cancer Res . 2024 Oct; 43(1):274. PMID: 39350250
Background: Somatic copy number alterations (SCNAs) are pivotal in cancer progression and patient prognosis. Dysregulated long non-coding RNAs (lncRNAs), modulated by SCNAs, significantly impact tumorigenesis, including colorectal cancer (CRC). Nonetheless,...
6.
Hou Y, Zhao Z, Li P, Cao Y, Zhang Y, Guo C, et al.
Biochim Biophys Acta Rev Cancer . 2024 Sep; 1879(6):189186. PMID: 39332651
The intractability and high mortality rate of castration-resistant prostate cancer (CRPC) remain the most challenging problems in the field of prostate cancer (PCa). Emerging evidence has shown that the dysregulation...
7.
Zhang H, Wei Y, Wang Y, Liang J, Hou Y, Nie X, et al.
Tissue Eng Part B Rev . 2024 Sep; 30(6):644-656. PMID: 39276101
The incidence of diabetes mellitus (DM) is steadily increasing annually, with 537 million diabetic patients as of 2021. Restoring diminished β cell mass or impaired islet function is crucial in...
8.
Liu Y, Zhu J, Zhou S, Hou Y, Yan Z, Ao X, et al.
MedComm (2020) . 2024 Aug; 5(8):e690. PMID: 39135916
Thyroid cancer incidence increases worldwide annually, primarily due to factors such as ionizing radiation (IR), iodine intake, and genetics. Papillary carcinoma of the thyroid (PTC) accounts for about 80% of...
9.
Zhu J, Ao X, Liu Y, Zhou S, Hou Y, Yan Z, et al.
Respir Res . 2024 Aug; 25(1):299. PMID: 39113018
Background: Although recent studies provide mechanistic understanding to the pathogenesis of radiation induced lung injury (RILI), rare therapeutics show definitive promise for treating this disease. Type II alveolar epithelial cells...
10.
Kang T, Hou Y, Liu D
Sensors (Basel) . 2024 Jul; 24(14). PMID: 39065843
This paper investigates the problem of synthesizing network attacks against fault diagnosis in the context of discrete event systems (DESs). It is assumed that the sensor observations sent to the...